Eric S. Winer, MD, on Metastatic Breast Cancer: Debate on a Research Tool

2017 San Antonio Breast Cancer Symposium
Tweet this page

Eric S. Winer, MD, of the Dana-Farber Cancer Institute, addresses the much-discussed controversy over whether all women diagnosed with metastatic breast cancer should undergo next-generation sequencing.

Advertisement

Advertisement



Advertisement